Mary Lynn Davis-Ajami

Mary Lynn Davis-Ajami

Auto-generated profile, based on publicly available information

Mary Lynn Davis-Ajami

Indiana University Bloomington

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
MDMary L. Davis-Ajami
Mary L. Davis-Ajami
ZLZhiqiang K. Lu
Zhiqiang K. Lu
JWJun Wu
Jun Wu


19 December 2019 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
MDMary Lynn Davis-Ajami
Mary Lynn Davis-Ajami
Kevin LuKevin Lu
Kevin Lu
JWJun Wu
Jun Wu
Background: Cancer increases the risk of developing one or more chronic conditions, yet little research describes the associations between health care costs, utilization patterns, and chronic conditions in adults with cancer. The objective of this study was to examine the treated prevalence of chronic conditions and the association between chronic conditions and health care expenses in US adults with cancer. Methods: This retrospective observational study used US Medical Expenditure Panel Survey (MEPS) Household Component (2010–2015) data sampling adults diagnosed with cancer and one or more of 18 select chronic conditions. The measures used were treated prevalence of chronic conditions, and total and chronic condition-specific health expenses (per-person, per-year). Generalized linear models assessed chronic condition-specific expenses in adults with cancer vs. without cancer and the association of chronic conditions on total health expenses in adults with cancer, respectively, by controlling for demographic and health characteristics. Accounting for the complex survey design in MEPS, all data analyses and statistical procedures applied longitudinal weights for national estimates. Results: Among 3657 eligible adults with cancer, 83.9% (n = 3040; representing 16 million US individuals per-year) had at least one chronic condition, and 29.7% reported four or more conditions. Among those with cancer, hypertension (59.7%), hyperlipidemia (53.6%), arthritis (25.6%), diabetes (22.2%), and coronary artery disease (18.2%) were the five most prevalent chronic conditions. Chronic conditions accounted for 30% of total health expenses. Total health expenses were $6388 higher for those with chronic conditions vs. those without (p < 0.001). Health expenses associated with chronic conditions increased by 34% in adults with cancer vs. those without cancer after adjustment. Conclusions: In US adults with cancer, the treated prevalence of common chronic conditions was high and health expenses associated with chronic conditions were higher than those without cancer. A holistic treatment plan is needed to improve cost outcomes.

1 June 2014 in Journal of Managed Care Pharmacy
Verified
Journal Article
Open access
JWJun Wu
Jun Wu
MDMary Lynn Davis-Ajami
Mary Lynn Davis-Ajami
BACKGROUND: Pregnant women with depression face complicated treatment decisions, either because of the risk associated with not treating depression or because of the risks associated with antidepressant use. Approximately 1 in 5 women experience depressive symptoms during pregnancy. This information suggests that many women may take an antidepressant at some time during pregnancy. Once pregnant women initiate antidepressant prescription pharmacotherapy, medication treatment persistence plays an important role in managing depression, yet little is known regarding antidepressant use behavior in pregnant women. OBJECTIVE: To determine antenatal antidepressant treatment nonpersistence and associated factors in low-income, insured pregnant women. METHODS: We identified eligible pregnant women (≥18 years) diagnosed with major depression who initiated antidepressant medications during pregnancy from South Carolina Medicaid claims data (2004-2009). Our main outcome measure was treatment nonpersistence to antidepr...

1 October 2021 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
AKAllisandra G. Kummer
Allisandra G. Kummer
MDMary Lynn Davis-Ajami
Mary Lynn Davis-Ajami
BABritney Arce
Britney Arce
KHKathryn Hartlieb
Kathryn Hartlieb
SDStephanie Dickinson
Stephanie Dickinson
Wasantha Parakrama JayawardeneWasantha Parakrama Jayawardene
Wasantha Parakrama Jayawardene

19 June 2019 in American Journal of Nephrology
Verified
Journal Article
Closed access
PDF file
MDMary Lynn Davis-Ajami
Mary Lynn Davis-Ajami
JFJeffery C. Fink
Jeffery C. Fink
MBMarianne Baernholdt
Marianne Baernholdt
JWJun Wu
Jun Wu
Background: Adverse safety events (ASE) during hospitalization may contribute to renal decline or poor outcomes. Understanding factors contributing to ASE in chronic kidney disease (CKD) is limited. The objective is to compare differences and determine predictors of renal pertinent ASE in discharges for CKD. Method: A cross-sectional analysis of the National Inpatient Sample, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality 2012 data. The study included adults age ≥18 years with discharge diagnosis for CKD stages 1–4, excluding cancer of the kidney and renal pelvis, renal transplant, end-stage renal disease. Predictors included study sample characteristics, including patient demographics, comorbidity, and hospitalization-related variables. Outcomes assessed included distribution of ASE (angioedema, confusion, muscle weakness or cramps, lower extremity edema (LEE), falls, hypoglycemia, nausea-vomiting-diarrhea (NVD), and skin rash), mean total charge per hospital event, and length-of-stay. The analytical approach used descriptive statistics (means and proportions) and bivariate analysis to compare differences (ASE versus none). Predictors of ASE were explored using multivariate logistic regression. Results: 10.3% of inpatient discharges for CKD showed an ASE. Mean charges (USD 48,072 vs. 46,996), days length-of-stay (6.8 vs. 5.7), number of diagnosis on record (6.8 vs. 5.7), geographical region (Midwest, and West), and type of hospital (rural) were significantly associated with ASE. Most common ASEs were confusion (18%), LEE (21.3%), and NVD (50.7%). Odds of ASE increased for age, female gender, rural hospitals, geographical region, and diagnosis for anemia, coagulopathies, depression, fluid and electrolyte disorders, neurological disorders, psychoses, and weight loss. Conclusions: We identified key factors that increase the risk of ASE in patients with CKD. Opportunities exist to reduce ASE in CKD.